학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 248건 | 목록
1~20
Academic Journal
Tawbi, Hussein A ; Burgess, Melissa ; Bolejack, Vanessa ; Van Tine, Brian A ; Schuetze, Scott M ; Hu, James ; D'Angelo, Sandra ; Attia, Steven ; Riedel, Richard F ; Priebat, Dennis A ; Movva, Sujana ; Davis, Lara E ; Okuno, Scott H ; Reed, Damon R ; Crowley, John ; Butterfield, Lisa H ; Salazar, Ruth ; Rodriguez-Canales, Jaime ; Lazar, Alexander J ; Wistuba, Ignacio I ; Baker, Laurence H ; Maki, Robert G ; Reinke, Denise ; Patel, Shreyaskumar
In The Lancet Oncology November 2017 18(11):1493-1501
Academic Journal
Brand M; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.; Adamik J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Currently: Merck Research Labs, South San Francisco, CA, USA.; Wang H; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA.; Sember SE; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Muzzio JL; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Buffo MJ; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Sander CA; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Kirkwood JM; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Ferris RL; UNC Lineberger Comprehensive Cancer Center, UNC Health Care System, Chapel Hill, NC, USA.; Butterfield LH; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Currently: Merck Research Labs, South San Francisco, CA, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA.; Vujanovic L; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Academic Journal
Zhao, Xi ; Bose, Anamika ; Komita, Hideo ; Taylor, Jennifer L ; Kawabe, Mayumi ; Chi, Nina ; Spokas, Laima ; Lowe, Devin B ; Goldbach, Christina ; Alber, Sean ; Watkins, Simon C ; Butterfield, Lisa H ; Kalinski, Pawel ; Kirkwood, John M ; Storkus, Walter J
In Molecular Therapy April 2011 19(4):805-814
Academic Journal
Gordon, Lynn K ; Ribas, Antoni ; Nusinowitz, Steven ; Butterfield, Lisa H ; Glaspy, John A ; Economou, James S ; Straatsma, Bradley R
In Controlled Clinical Trials 2004 25(4):400-407
Academic Journal
Mirabile-Brightman SE; Center for Cancer Immunotherapy, La Jolla Institute for Immunology , La Jolla, CA, USA.; Butterfield LH; Merck Research Laboratories , South San Francisco, CA, USA.
Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Academic Journal
Meng, Wilson S ; Butterfield, Lisa H ; Ribas, Antoni ; Heller, Justin B ; Dissette, Vivian B ; Glaspy, John A ; McBride, William H ; Economou, James S
In Molecular Immunology November 2000 37(16):943-950
Academic Journal
Tarhini AA; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Obermayer A; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, Florida.; Lee SJ; Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; LaFramboise WA; Pathology and Laboratory Medicine Department, Allegheny Cancer Institute, Allegheny Health Network, Pittsburgh, Pennsylvania.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Karunamurthy AD; Department of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania.; Eljilany I; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Chen DT; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, Florida.; Hwu P; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; El Naqa IM; Department of Machine Learning, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Streicher H; Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland.; Sondak VK; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Storkus WJ; Department of Dermatology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.; Butterfield LH; Merck Research Laboratories, Boston, Massachusetts.; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California.; Shaw TI; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center, Tampa, Florida.; Kirkwood JM; Division of Hematology-Oncology, Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Wargo, Jennifer A; Schumacher, Lana Y; Comin-Anduix, Begonya; Dissette, Vivian B; Glaspy, John A; McBride, William H; Butterfield, Lisa H; Economou, James S; Ribas, Antoni
Academic Journal
Quandt Z; Department of Medicine, Division of Endocrinology and Metabolism, UCSF, San Francisco, California, USA.; Diabetes Center, UCSF, San Francisco, California, USA.; Lucas A; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Liang SI; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Yang E; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Stone S; Division of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Fadlullah MZH; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Departments of Oncological Sciences and Biomedical Informatics, University of Utah, Salt Lake City, Utah, USA.; Bayless NL; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Marr SS; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Thompson MA; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Padron LJ; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Bucktrout S; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Microbiology and Immunology, University of California, San Francisco, California, USA.; Tan AC; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Departments of Oncological Sciences and Biomedical Informatics, University of Utah, Salt Lake City, Utah, USA.; Herold KC; Department of Immunobiology, Yale University, New Haven, Connecticut, USA.; Department of Internal Medicine, Division of Endocrinology and Metabolism, Yale University, New Haven, Connecticut, USA.; Bluestone JA; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Anderson MS; Department of Medicine, Division of Endocrinology and Metabolism, UCSF, San Francisco, California, USA.; Diabetes Center, UCSF, San Francisco, California, USA.; Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Young A; Division of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah, USA.; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Connolly JE; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA jconnolly@parkerici.org.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Boyiadzis, Michael ; Agha, Mounzer ; Redner, Robert L ; Sehgal, Alison ; Im, Annie ; Hou, Jing-Zhou ; Farah, Rafic ; Dorritie, Kathleen A. ; Raptis, Anastasios ; Lim, Seah H. ; Klingemann, Hans ; Wang, Hong ; Lapteva, Natalia ; Zhuyong, Mei ; Butterfield, Lisa H ; Rooney, Cliona M. ; Whiteside, Theresa L
In Blood 2 December 2016 128(22):1649-1649
Academic Journal
Ribas, Antoni; Butterfield, Lisa H; McBride, William H; Dissette, Vivian B; Koh, Andrew; Vollmer, Charles M; Hu, Billy; Chen, Angela Y; Glaspy, John A; Economou, James S
Academic Journal
Adamik J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA.; Munson PV; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA.; Maurer DM; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA.; Hartmann FJ; Systems Immunology and Single-Cell Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bendall SC; Department of Pathology, Stanford University, Palo Alto, CA, 94304, USA.; Argüello RJ; Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.; Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA. lisa.butterfield@ucsf.edu.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. lisa.butterfield@ucsf.edu.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Alayli FA; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Okrah K; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Drakaki A; University of California, Los Angeles , Los Angeles, CA, USA.; Khalil DN; Memorial Sloan Kettering Cancer Center , New York, NY, USA.; Kummar S; Stanford University , Stanford, CA, USA.; Khan SA; Stanford University , Stanford, CA, USA.; Hodi FS; Dana-Farber Cancer Institute , Boston, MA, USA.; Parker Institute for Cancer Immunotherapy, Dana-Farber Cancer Institute , Boston, MA, USA.; Oh DY; University of California, San Francisco , San Francisco, CA, USA.; Cabanski CR; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Gautam S; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Meier SL; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Stanford University , Stanford, CA, USA.; Amouzgar M; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Pfeiffer SM; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Kageyama R; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Yang E; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Spasic M; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Foo WC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hollmann TJ; Memorial Sloan Kettering Cancer Center , New York, NY, USA.; Bristol Myers Squibb , New York, NY, USA.; Li Y; Memorial Sloan Kettering Cancer Center , New York, NY, USA.; Adamow M; Memorial Sloan Kettering Cancer Center , New York, NY, USA.; Wong P; Memorial Sloan Kettering Cancer Center , New York, NY, USA.; Moore JS; University of Pennsylvania , Philadelphia, PA, USA.; Velichko S; Natera Inc. , Austin, TX, USA.; Chen RO; Personalis Inc. , Fremont, CA, USA.; Kumar D; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Bucktrout S; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Ibrahim R; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Dugan U; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Salvador L; Bristol Myers Squibb , New York, NY, USA.; Hubbard-Lucey VM; Cancer Research Institute , New York, NY, USA.; O'Donnell-Tormey J; Cancer Research Institute , New York, NY, USA.; Santulli-Marotto S; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Butterfield LH; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Da Silva DM; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Fairchild J; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; LaVallee TM; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Padrón LJ; Parker Institute for Cancer Immunotherapy , San Francisco, CA, USA.; Sharma P; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; James P. Allison Institute, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.; Immunotherapy Platform, James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Academic Journal
Melanoma Research, vol 29, iss 2
Academic Journal
Adamik J; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, Suite D3500, 1 Letterman Drive, San Francisco, CA 94129, USA.; Butterfield LH; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, Suite D3500, 1 Letterman Drive, San Francisco, CA 94129, USA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Adamik J; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA.; Munson PV; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA.; Hartmann FJ; Systems Immunology and Single-Cell Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Combes AJ; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA.; CoLabs, University of California San Francisco, San Francisco, CA, USA.; Pierre P; Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.; Institute for Research in Biomedicine (iBiMED) and Ilidio Pinho Foundation, Department of Medical Sciences, University of Aveiro, 3810-193, Aveiro, Portugal.; Shanghai Institute of Immunology, Department of Microbiology and Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, PR China.; Krummel MF; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; ImmunoX Initiative, University of California San Francisco, San Francisco, CA, USA.; Bendall SC; Department of Pathology, Stanford University, Palo Alto, CA, 94304, USA.; Argüello RJ; Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France. arguello@ciml.univ-mrs.fr.; Butterfield LH; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA. lbutterfield@parkerici.org.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. lbutterfield@parkerici.org.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Butterfield LH; University of California San Francisco, Microbiology and Immunology, San Francisco, CA, USA. lisa.butterfield@ucsf.edu.; Najjar YG; UPMC Hillman Cancer Center, Pittsburgh, PA, USA. najjaryg@Upmc.edu.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1741 (Electronic) Linking ISSN: 14741733 NLM ISO Abbreviation: Nat Rev Immunol Subsets: MEDLINE
Academic Journal
Karasarides, Maria; Cogdill, Alexandria P; Robbins, Paul B; Bowden, Michaela; Burton, Elizabeth M; Butterfield, Lisa H; Cesano, Alessandra; Hammer, Christian; Haymaker, Cara L; Horak, Christine E; McGee, Heather M; Monette, Anne; Rudqvist, Nils-Petter; Spencer, Christine N; Sweis, Randy F; Vincent, Benjamin G; Wennerberg, Erik; Yuan, Jianda; Zappasodi, Roberta; Lucey, Vanessa M Hubbard; Wells, Daniel K; LaVallee, Theresa
Cancer Immunology Research, vol 10, iss 4
Bucktrout SL; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA. sbucktrout@parkerici.org.; Banovich NE; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.; Butterfield LH; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Cimen-Bozkus C; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Giles JR; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Good Z; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Stanford Cancer Institute and Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Goodman D; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Microbiology and Immunology, School of Medicine, University of California San Francisco, San Francisco, CA, USA.; Jonsson VD; Department of Applied Mathematics, University of California, Santa Cruz, Santa Cruz, CA, USA.; Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.; Genomics Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.; Lareau C; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Marson A; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Gladstone-UCSF Institute for Genomic Immunology, San Francisco, CA, USA.; Maurer DM; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Munson PV; Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.; Stubbington M; 10x Genomics, Pleasanton, CA, USA.; Taylor S; 10x Genomics, Pleasanton, CA, USA.; Cutchin A; 10x Genomics, Pleasanton, CA, USA.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Expert Review of Neurotherapeutics. October, 2013, Vol. 13 Issue 10, p1089, 10 p.
검색 결과 제한하기
제한된 항목
[AR] Butterfield, Lisa H
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어